Search results for “Chronic phase chronic myelogenous leukemia” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 203 patents, we discovered top 67 key players by total patent application. Amgen, Inc., Eli Lilly & Co., NATCO Pharma Ltd. are dominant in this area. They take 26.11% of the total patent filing.
Amgen, Inc.
California, United States
Patent: 35
Eli Lilly & Co.
Indiana, United States
Patent: 9
NATCO Pharma Ltd.
Andhra Pradesh, India
Patent: 9
Sanofi-Aventis SA
Spain
Patent: 8
Novartis AG
Basel-Stadt, Switzerland
Patent: 7
Teva Pharmaceuticals Australia Pty Ltd
United States
Patent: 6
Exelixis, Inc.
California, United States
Patent: 5
Orchid Pharma Ltd.
Tamil Nadu, India
Patent: 5
Pfizer Inc.
New York, United States
Patent: 4
Deciphera Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 10 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Dana-Farber Cancer Institute, Inc., Eli Lilly & Co., Shenzhen Feith Biotechnology Co., Ltd. take 40.00% of patent filing during this period.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 2
Eli Lilly & Co.
Indiana, United States
Patent: 1
Shenzhen Feith Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
Vestlandets Innovasjonsselskap AS
Hordaland, Norway
Patent: 1
The Children's Medical Center Corp.
Massachusetts, United States
Patent: 1
Handa Pharmaceuticals, Inc.
Taiwan Province, China
Patent: 1
Guizhou University
Guizhou Sheng, China
Patent: 1
Key Laboratory of Natural Product Chemistry, Chinese Academy of Sciences, Guizhou Province
undefined undefined
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 10 patents in last 5 years, we discover 6 new entrants. Dana-Farber Cancer Institute, Inc., Shenzhen Feith Biotechnology Co., Ltd., Vestlandets Innovasjonsselskap AS are the most active new entrants in this area.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 2
Shenzhen Feith Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
Vestlandets Innovasjonsselskap AS
Hordaland, Norway
Patent: 1
Handa Pharmaceuticals, Inc.
Taiwan Province, China
Patent: 1
Guizhou University
Guizhou Sheng, China
Patent: 1
Key Laboratory of Natural Product Chemistry, Chinese Academy of Sciences, Guizhou Province
undefined undefined
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 48 patents, we discovered top 17 universities and scientific research institutions by total patent application. Council of Scientific & Industrial Research, Hiroshima University, Consejo Superior de Investigaciones Científicas are dominant in this area. They take 25.00% of the total patent filing.
Council of Scientific & Industrial Research
Delhi, India
Patent: 3
Hiroshima University
Hiroshima-ken, Japan
Patent: 3
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 3
Northwestern University
Illinois, United States
Patent: 2
Case Western Reserve University
Ohio, United States
Patent: 2
Waseda University
Tokyo-to, Japan
Patent: 2
National & Kapodistrian University of Athens
Greece
Patent: 2
Korea Institute of Science & Technology
South Korea
Patent: 2
The University of Queensland
Queensland, Australia
Patent: 1
University of Massachusetts
Massachusetts, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: